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Increased sleep need and daytime sleepiness
6 months after traumatic brain injury: a
prospective controlled clinical trial
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Post-traumatic sleep-wake disturbances are common after acute traumatic brain injury. Increased sleep need per 24 h and excessive
daytime sleepiness are among the most prevalent post-traumatic sleep disorders and impair quality of life of trauma patients.
Nevertheless, the relation between traumatic brain injury and sleep outcome, but also the link between post-traumatic sleep
problems and clinical measures in the acute phase after traumatic brain injury has so far not been addressed in a controlled
and prospective approach. We therefore performed a prospective controlled clinical study to examine (i) sleep-wake outcome after
traumatic brain injury; and (ii) to screen for clinical and laboratory predictors of poor sleep-wake outcome after acute traumatic
brain injury. Forty-two of 60 included patients with ﬁrst-ever traumatic brain injury were available for follow-up examinations. Six
months after trauma, the average sleep need per 24 h as assessed by actigraphy was markedly increased in patients as compared to
controls (8.3  1.1 h versus 7.1  0.8 h, P50.0001). Objective daytime sleepiness was found in 57% of trauma patients and 19%
of healthy subjects, and the average sleep latency in patients was reduced to 8.7  4.6min (12.1  4.7min in controls, P = 0.0009).
Patients, but not controls, markedly underestimated both excessive sleep need and excessive daytime sleepiness when assessed only
by subjective means, emphasizing the unreliability of self-assessment of increased sleep propensity in traumatic brain injury
patients. At polysomnography, slow wave sleep after traumatic brain injury was more consolidated. The most important risk
factor for developing increased sleep need after traumatic brain injury was the presence of an intracranial haemorrhage. In
conclusion, we provide controlled and objective evidence for a direct relation between sleep-wake disturbances and traumatic
brain injury, and for clinically signiﬁcant underestimation of post-traumatic sleep-wake disturbances by trauma patients.
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Introduction
Sleep-wake disturbances (SWD) are frequent following
acute traumatic brain injury (TBI) and impair quality of
life in TBI patients. Several studies highlighted the high
prevalence of excessive daytime sleepiness (EDS) and
increased sleep need after TBI (Guilleminault et al., 1983;
Masel et al., 2001; Ouellet and Morin, 2006; Parcell et al.,
2006; Baumann et al., 2007; Castriotta et al., 2007;
Chaumet et al., 2008; Schreiber et al., 2008; Ponsford
et al., 2013). In a recent meta-analysis of 21 clinical studies,
50% of TBI patients suffered from post-traumatic SWD:
increased sleep need per 24 h and EDS were among the
most common and disturbing post-traumatic SWD
(Mathias and Alvaro, 2012). However, the reported preva-
lence of post-traumatic SWD varies considerably. This is
because the presently available studies differ signiﬁcantly
regarding study design (mostly retrospective studies), as-
sessment of sleep problems (questionnaires versus sleep la-
boratory examinations) and inconsistent deﬁnitions of
SWD resulting in a considerable variance regarding preva-
lence of SWD after TBI. To address the problem of hetero-
geneous deﬁnitions of SWD, we recently introduced the
term ‘post-traumatic pleiosomnia’ for increased sleep need
following TBI (Sommerauer et al., 2013). Earlier, this
symptom was referred to as post-traumatic hypersomnia,
but the concept of hypersomnia comprises both increased
sleep need per 24 h and EDS (American Academy of
Sleep Medicine, 2005) and is therefore misleading,
particularly for TBI patients who may suffer from either
EDS or excessive sleep need or from both (Baumann
et al., 2007).
The pathophysiology of EDS and pleiosomnia after TBI
remains elusive. However, fatal TBI is associated with a
partial loss of wake-promoting hypocretin (orexin)- and
histamine-producing neurons (Baumann et al., 2009;
Valko et al., 2014). This suggests that damage to hypothal-
amic neurons and to other wake-promoting neuronal popu-
lations might be associated with post-traumatic EDS and
pleiosomnia, but there are no acute biomarkers to predict
the evolution of these SWD. For instance, it has not been
examined whether acute dysfunction in neuro-endocrine
pathways involving the hypothalamic-pituitary-adrenal
axis is related to the development of increased sleep pro-
pensity after TBI.
In this study, we examined the prevalence and electro-
physiological characteristics of post-traumatic EDS and
pleiosomnia in a prospective and controlled approach by
systematically examining TBI patients 6 months after injury
with both subjective and objective sleep measures in com-
parison to an age- and gender-matched control group.
Furthermore, we tested whether sleep was more consoli-
dated after TBI and whether TBI was associated with a
relative increase in EEG power density in the delta range.
These analyses were motivated by the hypothesis that
increased slow-wave activity is linked to neuronal recovery
(Stickgold et al., 2001; Carmichael and Chesselet, 2002;
Tononi and Cirelli, 2006). As secondary endpoint, we cor-
related neuroimaging and laboratory measures reﬂecting
neuronal damage in general, and more speciﬁcally dysfunc-
tion in the hypothalamic-pituitary-adrenal axis in the acute
phase of TBI with the occurrence of post-traumatic SWD, to
identify potential early predictors of post-traumatic EDS and
pleiosomnia. The rationale to screen for hormonal disturb-
ances in TBI patients as possible predictors of SWD was
based on the hypothesis that shearing injuries may cause
loss of hormone-releasing neurons in the brainstem and
hypothalamus, and would possibly result in the disruption
of neuro-endocrine pathways, similar to the loss of hypocre-
tin-producing neurons after TBI (Baumann et al., 2009).
Materials and methods
The protocol for this clinical study was approved by the local
ethics committee (Kantonale Ethikkommission Zurich).
Written informed consent for study participation was obtained
from all patients and healthy controls before participation.
Study design
This is a prospective controlled trial to examine the prevalence,
severity, and natural history of SWD after TBI in relation to
severity of trauma (Glasgow Coma Scale), presence of brain
damage (intracranial haemorrhage), and selected neurochem-
ical biomarkers. Patients were examined at two time points: (i)
in the acute phase after TBI for clinical staging, brain CT scan
and laboratory assessment; and (ii) 6 months after TBI for a
detailed analysis of sleep and wakefulness (2-week actigraphy,
followed by nocturnal video-polysomnography and multiple
sleep latency tests, MSLT) and follow-up laboratory assess-
ment (Fig. 1).
Participants
Between July 2009 and June 2012, we screened 140 patients
with acute, ﬁrst-ever TBI admitted to our hospital and
included 60 patients. Patients with prior TBI, other neuro-
logical or systemic diseases, drug or alcohol abuse, or psychi-
atric comorbidities were excluded.
For the analyses of sleep and wakefulness, we enrolled an
age- and gender-matched healthy control group without prior
TBI. For this purpose, we prospectively searched for controls
by word-of-mouth advertising. To achieve optimal controlling
of the sleep-wake outcome measures, we introduced a novel
strategy for matching the control group: to achieve similar
extents of sleep satiation before sleep laboratory examinations,
we matched for the difference of total sleep times on actigra-
phy between working days and weekends/holidays, because
this difference reﬂects chronic sleep restriction during work-
days. By this additional matching, we could therefore rule
out a possible bias in the assessment of sleep measures due
to chronic sleep restriction. Both after screening and again
after sleep-wake assessments in the sleep laboratory, partici-
pants with SWD including circadian rhythm disorders on acti-
graphy were excluded as controls. Furthermore, volunteers
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with neurological disorders, a history of SWD or psychiatric
illnesses were excluded, as well as parents with young children
or subjects on shift work. To get a representative rather than
an artiﬁcial control sample (Mignot et al., 2006), apnoea-
hypopnoea indices (AHI) from 5 to 15 on polysomnography
or mean sleep latencies from 5 to 8min on MSLT were ac-
cepted for inclusion as control if no subjective EDS was indi-
cated by the Epworth Sleepiness Scale. Sleep laboratory
examinations in controls were performed only once. Six con-
trols were included in a previous study (Sommerauer et al.,
2013).
Examinations in the acute phase after
traumatic brain injury
We categorized the severity of TBI using the Glasgow Coma
Scale (13–15: mild; 9–12: moderate; and 3–8: severe) on ad-
mission to the hospital. Furthermore, we performed a CT scan
within the ﬁrst 4 h after trauma to estimate severity and local-
ization of brain injury.
Laboratory examinations within the ﬁrst 5 days after trauma
included the assessments of the hypothalamic-pituitary-adrenal
axis (adrenocorticotropic hormone, cortisol, and aldosterone,
adrenaline, noradrenaline, dopamine), and of serum bio-
markers reﬂecting neural injury and indicating poor overall
recovery after TBI (S100 calcium binding protein B, S100B,
and neuron-speciﬁc enolase, NSE; Berger et al., 2002;
Lamers et al., 2003; Vos et al., 2004). The same blood tests
were performed again 6 months after TBI.
Assessment of sleep-wake
disturbances 6 months after
traumatic brain injury
We screened for changes in sleep habits, sleep quality, daytime
vigilance and insomnia by detailed and structured interviews.
Patients and controls completed validated questionnaires such
as the Epworth Sleepiness Scale, the Sleep Apnoea Scale of the
Sleep Disorders Questionnaire, the Ullanlinna Narcolepsy Scale
and the Fatigue Severity Scale. We further investigated psycho-
logical mood, fatigue, and quality of life using reliable and
widely used self-report measures, and the ‘Allgemeine
Depressionsskala’ (ADS) to assess depressive symptoms
(Hautzinger and Bailer, 1993).
To screen for circadian SWD and to quantify sleep need per
24 h, patients and controls were examined with sleep logs and
wrist actigraphy (Actiwatch, Neurotechnology, King et al.,
2005). Wrist actigraphy was recorded and analysed as
described before (Cippa et al., 2013).
Thereafter, we performed overnight video-polysomnography
from 11p.m. to 7 a.m. as described previously (Baumann
et al., 2007). Sleep-stage scoring was performed visually ac-
cording to revised international criteria (Iber et al., 2007) and
sleep stage distribution was assessed by calculating the relative
time in each sleep behavioural state. For further signal process-
ing of the raw data, we used MatLab (The MathWorks Inc.
2009). We calculated delta power in slow-wave sleep as fol-
lows: ﬁrst, all 30-s epochs that were scored as non-rapid eye
movement (NREM) sleep stage 3 were included. This data set
Figure 1 Overview of study design and patient enrolment. Explanations for loss to follow-up are given in the results section of the
manuscript.
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was then subdivided into epochs of 5-s length. Artefacts were
rejected by an automated dual algorithm based on a short-
term kurtosis measure (mainly for electrode artefacts) and spec-
tral information (e.g. movement artefacts). Fast Fourier
Transformation was then applied on each 5-s epoch after multi-
plication by a Hann window to address the problem of edge
discontinuities (zero padding was used to expand the signal in
each 5-s epoch of 500 data points to a window size of 512
points). For better comparability between subjects, the calcu-
lated delta power (0.5–4.5Hz) was normalized to the total spec-
tral power (1–50Hz) for each individual. To calculate a
quantitative measure of sleep fragmentation, we ﬁrst assessed
the total number of behavioural state bouts. A behavioural
state bout was deﬁned as a consecutive series of epochs in the
same behavioural state without state transitions. The resulting
amount of behavioural state bouts was then divided by the total
number of 5-s epochs in the same sleep stage. This sleep frag-
mentation index reﬂects therefore the relative number of behav-
ioural state bouts per time (e.g. highly fragmented sleep with
many changes in sleep-wake behavioural states will result in a
high sleep fragmentation index). We chose 5-s epochs for this
analysis because the artefact rejection algorithm was based on
this time interval, but sleep stage classiﬁcation was based on the
classical 30-s epoch length (Iber et al., 2007).
Objective EDS was assessed by standardized MSLT. Brieﬂy,
the procedure entails four opportunities for sleep lasting
20min every 2 h; subjects were told to relax, and sleep was
permitted. Sleepiness was then assessed by mean sleep latencies
as derived from the concurrent EEG in the absence of external
alerting factors. Mean sleep latencies below 8min were con-
sidered to represent objective EDS (American Academy of
Sleep Medicine, 2005).
Statistical analyses
We used means, proportions and quartiles for descriptive com-
parative analysis of continuous data. TBI patients and controls
were compared with unpaired two-sided t-tests and data from
TBI patients at different time points with paired t-tests. More
than two groups were compared by one-way ANOVA. We
used 2-statistics to compare nominal data. To compare ob-
jective and subjective EDS (i.e. comparison between MSLT
versus Epworth Sleepiness Scale), we used McNemar’s test to
account for marginal homogeneity (i.e. to test the null hypoth-
esis whether subjective and objective assessment do not differ
signiﬁcantly). Bivariate correlation analysis was done by calcu-
lation of Pearson’s correlation coefﬁcient to reveal signiﬁcant
relations between clinical characteristics or endocrine markers
with sleep outcome measures.
Furthermore, we performed a subgroup analysis for the TBI
patients with respect to severity of TBI (mild versus severe TBI)
and compared the two groups by one-way ANOVA. For all
analyses, two-tailed P-values5 0.05 were considered to be
signiﬁcant.
Results
Of 140 screened patients, 33 were excluded because of
substance abuse or neurological, sleep–wake or psychiatric
disorders prior to TBI, and 47 patients denied to
participate, resulting in a cohort of 60 TBI patients
(range 18–71 years, 74% male). Forty-two out of these
patients with ﬁrst-ever traumatic brain injury and no
prior SWD were available for follow-up examinations 6
months after TBI (Fig. 1). After acute phase examinations,
18 participants were lost to follow-up for various reasons
(new onset of severe TBI-unrelated disease: n = 1, work:
n = 2, moved to a foreign country: n = 2, socioeconomic
problems: n = 1, new onset epilepsy: n = 1, no reason
given: n = 11). Except for one subject in the severe TBI
group, all TBI patients had ADS scores below the cut-off
of 23, indicating that all but one TBI patient did not suffer
from clinical depression. Thirty-one of 42 patients with full
sleep laboratory assessments had complete serum labora-
tory results in both the acute and the 6-month phase.
Post-traumatic pleiosomnia and
excessive daytime sleepiness
Continuous actigraphy assessment over 2 weeks conﬁrmed
pleiosomnia in TBI patients: we found that TBI patients
slept 1.2 h more per 24 h (8.3  1.1 h, mean  SD) than
controls (7.1  0.8 h, mean  SD, t-test: P5 0.0001,
Fig. 2A). On MSLT, average sleep latency was
12.1  4.7min in controls and 8.7  4.6min in TBI pa-
tients (t-test: P5 0.001, Fig. 2B). Total sleep time in poly-
somnography was signiﬁcantly longer in TBI patients
(392  10min in controls and 419  7min in TBI patients,
t-test: P50.05, Fig. 2C). Objective EDS (deﬁned as a mean
sleep latency 58min) was found in 57% of TBI patients as
compared to 19% in healthy subjects (Fig. 3A, 2 test:
P =0.001, Cramer’s ’: 0.39), resulting in an odds ratio of
5.6 (conﬁdence interval: 2.1–15.1) for TBI patients versus
healthy controls (Fig. 3A). Other causes than TBI of
increased EDS and pleiosomnia such as sleep apnoea or
insufﬁcient sleep syndrome were not present (no difference
between groups, Table 1). TBI patients did not show signs
of circadian dysfunction in actigraphy.
Sleep state misperception after trau-
matic brain injury
Subjective EDS and fatigue were assessed by the Epworth
Sleepiness Scale and the Fatigue Severity Scale, and subject-
ive sleep time per 24 h by sleep logs. Although objective
EDS and sleep need per day differed signiﬁcantly between
patients and controls, we found no signiﬁcant differences of
these subjective measures between the two groups (Table 2
and Fig. 3B). Similarly, when comparing the objective
against subjective EDS evaluation, we found no signiﬁcant
differences for controls, whereas in TBI patients objective
EDS was markedly more pronounced than recorded by
subjective assessment (Fig. 3B, McNemar objective versus
subjective: P-values4 0.99 in controls and 0.0004 in TBI
patients). In other words, 8 of 42 TBI patients (19%) re-
ported subjective EDS, but objective EDS was detected in
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24 of 42 patients (57%, P5 0.0005). Similarly, sleep logs
in controls showed no difference in sleep times between
sleep logs and actigraphy, but in TBI patients, sleep times
were underestimated by sleep logs when compared to acti-
graphy results (P = 0.002, Table 1).
Consolidated slow-wave sleep in
traumatic brain injury patients
Next, we addressed the question whether objective EDS
and pleiosomnia in TBI patients are related to changes of
sleep architecture or delta power of deep slow-wave sleep
(NREM3) during polysomnography. Consolidation of sleep
was assessed by calculation of a sleep fragmentation index
based on manual sleep scoring (see ‘Materials and methods’
section). This measure represents the average number of
behavioural state bouts per time (thus lower values indicate
a more consolidated sleep). In TBI patients, NREM3, but
also NREM1 and NREM2 sleep were signiﬁcantly more
consolidated (lower number of sleep bouts per time) than
in controls, whereas REM sleep was not altered (Fig. 4,
t-test: P = 0.002 for total effect). For the wake state, on
the other hand, we observed a higher fragmentation
index in TBI patients. Thus, whereas NREM sleep was
more consolidated after TBI, the wake state showed a
higher instability. These ﬁndings are in line with a trend
towards a higher amount of normalized delta power (0.5–
4.5Hz) in TBI patients that resulted in a 22% increase in
delta power (normalized delta power 0.44 in controls and
0.54 in TBI patients, t-test: P = 0.1, data not shown).
Similarly, we also found less wake after sleep onset in
the TBI group during polysomnography, although this
ﬁnding did not reach statistical signiﬁcance (Table 1).
Relative sleep stage distribution showed no signiﬁcant dif-
ference between TBI patients and controls (Table 1).
Severe trauma and intracranial hae-
morrhage as risk factors for
pleiosomnia
To identify predictors or risk factors for post-traumatic
SWD, we compared the sleep-wake outcome measures
with clinical and imaging TBI characteristics in the acute
phase. Correlation analysis revealed a strong dependence of
pleiosomnia on low initial Glasgow Coma Scale, i.e. high
TBI severity, and on haemorrhage as assessed by CT scans.
Pearson’s bivariate correlation coefﬁcients were R = 0.46
(P = 0.003) for pleiosomnia versus initial Glasgow Coma
Scale and R = 0.42 (P = 0.005) for pleiosomnia versus pres-
ence of intracranial haemorrhage (statistically controlled
for age and gender, Fig. 5A and D, full correlation not
shown). Occurrence and extent of pleiosomnia were not
associated with size or location of intracranial bleeding.
Other clinical measures such as age or gender had no in-
ﬂuence on sleep-wake outcome. In a subgroup analysis,
the sleep amount in the haemorrhage TBI group differed
signiﬁcantly from controls, as well as from the non-
haemorrhage TBI group (Fig. 5A and C), whereas in TBI
patients without intracranial haemorrhage the increased
sleep amount was not signiﬁcantly different from controls.
Mean sleep latency on MSLT, on the other hand, was
decreased in all TBI patients and did not differ between
patients with or without intracranial haemorrhage
(Fig. 5B). Similarly, the subgroup analysis for low severity
and high severity TBI based on initial Glasgow Coma Scale
revealed again that pleiosomnia depends on TBI severity
Figure 2 Sleep amount and sleep latency in TBI patients and healthy controls. (A) Daily hours of sleep as measured by continuous
actigraphy over 2 weeks, showing an increase of 1.2 h in total amount of sleep/24 h in TBI patients as compared to the control group. (B) Mean
sleep latencies on the MSLT in TBI patients are 28% lower than in healthy controls. (C) Total sleep time in 8 h-polysomnography (PSG) reveals an
increased amount of sleep in TBI patients. Box plots indicate means (horizontal line), upper and lower quartiles (box) and extrema (whiskers),
outliers are shown as black dots. ***P5 106, **P5 0.0001, *P5 0.05.
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and differed between high and low grade TBI patients,
whereas objective EDS was independent from the initial
Glasgow Coma Scale on hospital admission (Fig. 5D–F).
Correlation of sleep-wake outcome
with acute phase laboratory markers
To ﬁnd neurochemical predictors of post-traumatic sleep-
wake outcome, we assessed whether sleep-wake changes 6
months after trauma were related to the presence of serum
TBI markers, or to pathological levels of hypothalamo-
pituitary-adrenal hormones in the acute phase after TBI.
In a ﬁrst step, we compared these acute laboratory meas-
ures with follow-up values at the time of sleep evaluation
(6 months after TBI). Trauma markers such as NSE and
S100B were elevated in the acute phase (Fig. 6A) but had
no predictive value for sleep-wake outcomes. In terms of
neuro-endocrine parameters, only adrenaline levels were
signiﬁcantly elevated (Fig. 6A). Overall cortisol levels
were not changed, but we observed a change of the diurnal
cortisol pattern: in the acute phase, the circadian gradient
between morning and afternoon cortisol was ﬂattened, as
compared to the normal-more pronounced difference be-
tween a.m. and p.m. cortisol levels 6 months after TBI
(Fig. 6B). Next, we compared these neurochemical markers
with sleep-wake outcome parameters in a bivariate correl-
ation analysis and we found that decreased morning corti-
sol levels in the acute phase correlated signiﬁcantly with
objective EDS 6 months after TBI (Fig. 6C, R = 0.88,
P = 0.005, n = 10).
Discussion
We present the ﬁrst prospective and controlled clinical trial
to examine EDS and pleiosomnia—i.e. excessive sleep
need—in TBI patients by objective and subjective sleep
measures. Six months after TBI, we found a marked in-
crease of objective EDS and clinically relevant pleiosomnia
as compared to an age- and gender-matched control group.
Polysomnography revealed that NREM sleep in TBI
Figure 3 Objective versus subjective EDS in TBI patients
and controls. (A) Objective EDA (defined as average sleep latency
58 min on MSLT, filled bars) was found in 24/42 TBI patients (57%)
as compared to 8/42 healthy subjects (19%; odds ratio: 5.6,
P5 0.001). (B) Comparison of subjective EDS (based on Epworth
Sleepiness Scale, open bars) and objective EDS (based on MSLT,
filled bars). In healthy controls, no difference between subjective
and objective measures was found, but in TBI patients, EDS was
three times more prevalent when assessed objectively (McNemar
objective versus subjective EDS: P4 0.99 in controls and
**P5 0.0005 in TBI patients).
Table 1 Demographic data for TBI patients and
controls
Controls TBI P-value
Population characteristics
Age 36.5  13.2 35.5  14.4 0.84
Gender (M/F) 31/11 31/11 n.a.
Polysomnography
Total Sleep Time [min] 392  10 420  7 0.04
Sleep efficiency 87.6  2% 87.9  1.3% 0.98
Sleep latency (NREM2) [min] 31.9  6.7 23.7  2.8 0.27
Wake after sleep onset [min] 11.4  1.7 8.2  1.1 0.17
Arousal Index 7.7  0.8 6.0  0.6 0.09
PLMS Index 1.3  0.6 2.7  1.2 0.30
AHI 3.2  1 2.3  0.5 0.42
ODI 3.3  1 2.2  0.4 0.32
NREM1 9.1  0.7 9.9  1.2% 0.06
NREM2 41.2  1.4 43.9  1.3% 0.32
NREM3 20.2  1.2 20.1  1.0% 0.29
REM 18.1  0.9 18.0  1.0% 0.43
WAKE 11.4  1.7 8.2  1.1% 0.49
Actigraphy
Sleep time/24 h (actigraphy) 7.1  0.8# 8.3  1.1* P5 0.00001
Sleep time/24 h (sleep log) 7.3  1.1# 7.5  1.4* n.s
Difference WD/WE 0.4  0.8 0.5  0.8 n.s.
Relative amounts of sleep stages are given in percentage of total time in bed for
NREM1, NREM2, NREM3, REM sleep, and wakefulness. Sleep time/24 h
(actigraphy) = time asleep as measured by actigraphy recordings; Sleep time/24 h
(sleep log) = time asleep per 24 h as assessed by sleep logs; Difference WD/
WE = difference of daily hours of sleep between weekdays and weekends. P-values are
given for comparison of controls versus TBI patients. Sleep time per 24 h as assessed
objectively by actigraphy and sleep time per 24 h as reported on sleep logs did not
differ in controls (#, n.s), whereas sleep times were subjectively underestimated in TBI
patients (*P5 0.005, paired t-test). AHI = apnoea-hypopnoea index; PLMS = periodic
limb movements during sleep; ODI = oxygen desaturation index.
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patients is more consolidated than in controls, but the rela-
tive distribution of sleep stages is not different. The
observed increase in total delta power after TBI was not
signiﬁcant in our sample. In contrast to these objective
ﬁndings, TBI patients appear to underestimate both EDS
and pleiosomnia if only subjective measures such as sleep
logs or sleep questionnaires are applied.
The observed prevalence of post-traumatic EDS (57% of
TBI patients) is in line with previous uncontrolled or retro-
spective trials (Masel et al., 2001; Baumann et al., 2007;
Castriotta et al., 2007), and the observed prevalence of
EDS in controls is in general agreement with earlier ﬁnd-
ings in large community-based cohort studies (Mignot
et al., 2006). Our control group was not only matched
for age and gender, but also for difference of total sleep
times on actigraphy between working days and weekends/
holidays, i.e. for overall sleep satiation before polysomno-
graphy and MSLT. By controlling for this measure, we
were able to compare objective sleep-wake measures be-
tween groups without a potential bias due to chronic
sleep deprivation. Furthermore, by including also subjects
with sleep latencies58 min as controls, we were able to
compare TBI patients to a reliable and not overly prese-
lected healthy reference group, because moderate objective
daytime sleepiness is a frequent ﬁnding in healthy subjects
(Mignot et al., 2006). By doing this, we conﬁrm a signiﬁ-
cantly increased prevalence of EDS and of pleiosomnia and
conclude—in the absence of other potential causes of
SWD—that these are probably directly related to the
trauma. A potential confounding factor is the occurrence
of depression after TBI and development of secondary post-
traumatic SWD (e.g. insomnia). However, standardized
neuropsychiatric assessment revealed that only one TBI pa-
tient had scores suggestive of a clinical depression.
Therefore, we conclude that EDS and pleiosomnia in this
cohort of TBI patients is not caused or worsened by ac-
companying mood disorders.
Pleiosomnia was strongly correlated with both severe TBI
as assessed with the Glasgow Coma Scale and with the
presence of an intracranial haemorrhage upon CT scan in
the acute phase after TBI. This indicates that trauma pa-
tients with an objective correlate of severe TBI, i.e. intra-
cranial bleedings, are more susceptible to developing post-
traumatic pleiosomnia. Other clinical parameters such as
age or gender had no inﬂuence on the development of
post-traumatic pleiosomnia. Furthermore, as SWDs were
not associated with size or localization of bleedings, we
suggest that intracranial haemorrhage itself is not the
origin for poor sleep-wake outcome, but rather an indicator
of the severity of the trauma. We rather hypothesize that
patients with severe trauma may suffer more often from
direct or secondary lesions in the hypothalamus or rostral
brainstem, which are not accessible by CT scan. This might
lead to the otherwise observed loss of wake-promoting
neuronal systems with TBI, which could explain the occur-
rence of pleiosomnia. These deductions, however, lie
beyond the scope of the current study. More detailed
(MRI-based) neuroanatomical analyses in TBI patients are
needed to investigate the occurrence and distribution of
micro-lesions in the brainstem after TBI. In line with this,
we recently found a signiﬁcant loss of wake-promoting his-
taminergic cells in the hypothalamic tuberomammillary
Table 2 Subjective sleep measures for TBI patients and controls
TBI CONTROLS P-value Stat
Epworth Sleepiness Scale 6.1  3.1 5.6  3.3 0.64 (n.s.) t-test
FSS 3.0  1.1 2.7  1.3 0.23 (n.s.) t-test
Ullanlinna 7.0  3.5 6.2  3.2 0.42 (n.s.) t-test
SNS 17.5  17.0 22.6  13.2 0.54 (n.s.) t-test
Sleepiness yes/no 16 10 0.15 (n.s.) Chi-Square
SWD yes/no 12 10 0.61 (n.s.) Chi-Square
Epworth Sleepiness Scale410 8 7 0.77 (n.s.) Chi-Square
FSS = Fatigue Severity Scale; Ullanlinna = Ullanlinna Narcolepsy Scale; SNS = Swiss Narcolepsy Scale; Sleepiness yes/no = overall subjective as-
sessment of daytime sleepiness; SWD yes/no = overall subjective assessment of the presence of a sleep-wake disorder.
Figure 4 Sleep fragmentation in TBI patients and con-
trols. Sleep fragmentation (number of sleep bouts/time) is reduced
in NREM sleep in TBI patients (grey bars) as compared to controls
(black bars), whereas fragmentation of REM sleep did not differ.
Wakefulness was more fragmented in TBI patients (t-test:
**P5 0.005, *P5 0.05).
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nucleus (Valko et al., 2014). On the other hand, we cannot
exclude the possibility that other mechanisms that are
related to intracranial haemorrhage—such as vasospasms
that may affect cerebral blood ﬂow to the midbrain—
might contribute to increased sleep need (Cetas et al.,
2009). However, given the fact that recordings were
made 6 months after trauma, such mechanisms are likely
to be less relevant.
On the other hand, we might speculate whether increased
sleep need might be associated with the need for neuroplas-
ticity after TBI. It has been shown that synchronous slow
wave EEG activity is associated with neuronal plasticity or
synaptic strength, both during sleep and in the awake state
(Stickgold et al., 2001; Carmichael and Chesselet, 2002;
Tononi and Cirelli, 2006). Our ﬁnding of more consoli-
dated deep sleep and a tendency towards higher delta
power in NREM sleep might be in favour of such a
hypothesis. The percentage breakdown of sleep stages
was unaltered in TBI patients as compared to healthy con-
trols. In other words, TBI patients are in need for longer
sleep times, but still have the same relative amounts of sleep
stages. Altogether, our ﬁndings indicate that patients with
more severe TBI and higher levels of cellular or axonal
damage might be in need of longer sleep times per 24 h
and for more consolidated slow-wave sleep with higher
delta power. In this regard, it would be interesting to
learn whether overall sleep need and slow wave sleep
with increased delta power are even more accentuated
early on after TBI. This question could be addressed by
further studies.
We diagnosed pleiosomnia based on actigraphy record-
ings. It must be noted that decreased levels of activity might
have led to an overestimation of sleep times per 24 h.
This is why we double-checked actigraphy data with the
Figure 5 Pleiosomnia and excessive daytime sleepiness with respect to occurrence of intracranial haemorrhage and TBI
severity. (A) Patients with intracranial haemorrhage (ICB + ) had significantly more sleep per 24 h than both controls and TBI patients without
bleedings (ICB ). (B) Mean sleep latencies on MSLT differed between controls and TBI patients, but no significant difference was observed
between TBI patients with (ICB + ) and without (ICB ) intracranial bleeding (Pearson correlation: R = 0.292, P5 0.01). (C) Patients with
intracranial haemorrhage (ICB + ) showed increased total sleep time on polysomnography (PSG), whereas sleep time in patients without
haemorrhage (ICB ) did not differ from the control group. (D) Patients with severe TBI (Grade III, Glasgow Coma Scale4 8) had more sleep
per 24 h than both controls and mild TBI patients (Grade I, Glasgow Coma Scale5 13). (E) Mean sleep latencies on MSLT differed between
controls and TBI patients, but not between TBI patients with low and high severity trauma. (F) Patients with Grade III TBI had elevated total sleep
time in polysomnography as compared to controls. (***P5 0.001, **P5 0.01 *P5 0.05 in one-way ANOVA, n = 84).
Sleep need after traumatic brain injury BRAIN 2015: 138; 726–735 | 733
sleep logs that have been ﬁlled by the patients during acti-
graphy recordings. Furthermore, sleep laboratory examin-
ations in a controlled setting (MSLT, polysomnography;
Fig. 2B and C) conﬁrmed the occurrence of increased
sleep need in TBI patients. However, maximal sleep time
at polysomnography was limited to 8 h, which leads to a
quantitative underestimation of sleep need per 24 h, par-
ticularly in subjects with increased sleep need (48 h;
Fig. 5). Therefore and despite the given methodological
limitations, we believe that actigraphy delivers better in-
sights into total average sleep time per 24 h.
Post-traumatic EDS, on the other hand, occurs independ-
ently of traumatic intracranial haemorrhage and trauma
severity. In our population, many patients with minor
head trauma still developed clinically relevant EDS.
Therefore, other factors than direct neuronal damage
might inﬂuence post-traumatic EDS. In line with this,
analysis of neuro-endocrine markers revealed that ﬂattened
diurnal cortisol proﬁles and low a.m. cortisol levels correl-
ate with the development of post-traumatic EDS, i.e.
shorter sleep latency on MSLT. Impaired alertness
(Chapotot et al., 1998) and awakening problems have
been reported in patients with lowered cortisol levels
(Dijk et al., 2012). Thus, pathological cortisol signalling
seems to herald a subsequent evolution of midbrain-
driven EDS. Earlier studies have suggested that midbrain
structures are particularly vulnerable to TBI (Crompton,
1971a, b; Baumann et al., 2009). Considering our ﬁndings,
it seems that even mild TBI can lead to a relevant disturb-
ance in the central regulation of the hypothalamic-pituitary-
adrenal axis without any further brain damage or focal
neurological deﬁcits.
However, as an important limitation, this study was not
designed to account for diurnal cortisol changes. The ana-
lysis of a.m. and p.m. levels was done post hoc and there-
fore the correlation analysis was done only for patients in
whom a.m. and p.m. cortisol was available. Therefore, no
conclusion for TBI patients in general can be drawn at this
point and only future systematic approaches might reveal
whether or not diurnal cortisol level measurements might
be predictive of post-traumatic EDS.
Finally, many TBI patients with marked increase of ‘ob-
jective’ EDS in MSLT did not report ‘subjective’ EDS as
assessed by various sleep questionnaires. The same applies
for increased sleep need: pleiosomnia was obvious in TBI
patients as compared to controls, but sleep logs revealed
similar reported sleep times in both groups. In other words:
although TBI patients presented with pronounced objective
EDS and pleiosomnia, the applied subjective tests failed to
capture both EDS and pleiosomnia. These results indicate a
strong sleep state misperception in TBI patients. The reason
for this striking difference between objective and subjective
sleep measures remains unclear. As this study was not de-
signed to assess for anosognosia in TBI patients, this ques-
tion should be addressed in future studies by appropriate
neuropsychological assessments. From a clinical point of
view, this ﬁnding poses a diagnostic challenge, as standar-
dized and validated screening instruments for sleepiness or
hypersomnia (e.g. Epworth Sleepiness Scale, sleep logs, his-
tory-taking) obviously fail to detect SWD in TBI patients.
Consequently, considering these data and forensic conse-
quences of EDS (e.g. in patients driving motor vehicles),
TBI patients should be examined with sleep laboratory
examinations rather than self-reported sleep measures
whenever possible. As polysomnography is expensive and
time-consuming, further studies might elucidate whether
actigraphy and MSLT alone might be sufﬁcient.
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